Does the EPS have to cover care for biopolymer complications or for non-permitted modelling substances?

Yes, the Constitutional Court unified the jurisprudential rules and recognised that medical procedures for the removal and management of complications caused by biopolymers or non-permitted modelling substances are included in the Health Benefits Plan, and therefore, must be assumed by the EPS in order to protect health and dignified life (SU-239 of 2024).